Le Lézard
Classified in: Health, Business
Subject: CXP

Legacy Medical Consultants Announces Major Headquarters Expansion


FORT WORTH, Texas, April 24, 2024 /PRNewswire/ -- Legacy Medical Consultants today announced plans to more than double the size of its headquarters facilities to accommodate its expanding operations and portfolio of allografts for wound care.

The company has been growing steadily since its founding in 2020?with over 500 percent annualized growth in unit sales?a testament to the quality of its allografts, and commitment to patient needs.

"Our focus is on the well-being of patients who use our products," said Legacy Chief Executive Officer Jonathan Knutz. "Our goal is to make sure doctors have the highest quality allografts available to support their patients and improve the quality of their lives. Our expansion shows our commitment to serving our customers."

The new facility will be nearly 15,000 square feet and is located in Hillwood Development Company LLC's Alliance Town Center, the same building as the existing location. Legacy expects to move to the new offices by August.

The Class A office space will house employees focused on customer success and accounting, and serve as a hub for distribution. There will be an expanded climate-controlled storage area for allografts. There will also be a boardroom and training facilities, an essential component of teaching new staff about the company's values, which center around integrity and making life better for patients.

"Training and culture are very important to us," said Legacy Chief Operating Officer David Cornell. "Our new facility will help us embrace our culture and shows our commitment to wound care patients."

About Legacy Medical Consultants

Legacy Medical Consultants elevates patient care by addressing unmet clinical needs in wound patients. Legacy Medical Consultants' team of dedicated professionals serves both providers and their patients in the field of complex wound care. To learn more about LMC's portfolio of products please visit https://www.legacymedicalconsultants.com/.

SOURCE Legacy Medical Consultants


These press releases may also interest you

at 06:20
Li-Cycle to Host First Quarter 2024 Earnings Conference Call/Webcast on Friday, May 10, 2024 at 8:30 a.m. (Eastern Time)
Li-Cycle Holdings Corp. ("Li-Cycle" or the "Company"), a leading global lithium-ion battery resource recovery company, today announced plans to release its financial results and provide a business update for its first quarter ended March 31, 2024...

at 06:17
Novelis Reports Fourth Quarter and Full Fiscal Year 2024 Results
Q4 Fiscal Year 2024 Highlights Net income attributable to our common shareholder and net income from continuing operations of $166 million, up 6% YoY; Net income excluding special items was $179 million, up 2% YoYAdjusted EBITDA of $514 million, up...

at 06:15
Legal-Bay Lawsuit Funding Announces Increased Commitment to Product Liability Funding
Legal-Bay LLC, The Lawsuit Pre Settlement Funding Company, announced today their newfound focus on product liability claims for plaintiffs and lawyers involved in ongoing mass tort litigations. Due to increasing product liability lawsuit loan...

at 06:15
Shipium Partners With Blue Yonder To Drive Better, More Accurate Delivery Dates To Consumers
Shipium, the leading shipping platform for enterprise shippers and logistics service providers, today announced a partnership with Blue Yonder, a leader in digital supply chain transformations. Through the partnership, Shipium and Blue Yonder will...

at 06:05
GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline results from its Phase 3 global pivotal study of uproleselan in...

at 06:05
NW Natural Holdings Reports First Quarter 2024 Results
Northwest Natural Holding Company, (NW Natural Holdings), reported financial results and highlights including: Reported net income of $63.8 million ($1.69 per share) for the first quarter of 2024, compared to net income of $71.7 million ($2.01...

More news about Business...


News published on and distributed by: